BCI
VIVO

Brinker Capital Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Brinker Capital Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,001
Closed -$531K – 1683
2022
Q4 		$531K Sell
16,001
-16,224
-50% -$523K 0.01% 956
2022
Q3 		$1.02M Sell
32,225
-4,757
-13% -$154K 0.02% 704
2022
Q2 		$1.13M Sell
36,982
-8,272
-18% -$224K 0.02% 692
2022
Q1 		$1.18M Buy
45,254
+1,376
+3% +$32.7K 0.02% 739
2021
Q4 		$895K Sell
43,878
-9,754
-18% -$187K 0.01% 858
2021
Q3 		$1.19M Hold
53,632
– – 0.02% 714
2021
Q2 		$1.19M Sell
53,632
-11,039
-17% -$234K 0.02% 765
2021
Q1 		$1.7M Buy
64,671
+50,359
+352% +$1.2M 0.03% 559
2020
Q4 		$267K Sell
14,312
-34,960
-71% -$653K ﹤0.01% 949
2020
Q3 		$837K Buy
+49,272
New +$958K 0.01% 740

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brinker Capital Investments's VIVO Position: Q1 2023 in Review

Brinker Capital Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 16,001 shares — an estimated $531K sold.

Brinker Capital Investments first reported a position in VIVO in Q3 2020 and held it in 10 quarters. The position peaked at $1.7M in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Brinker Capital Investments reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 16,001 Meridian Bioscience Inc shares in Q1 2023, an estimated $531K.
  • Brinker Capital Investments first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 10 quarters.
  • Brinker Capital Investments's Meridian Bioscience Inc position peaked at $1.7M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Brinker Capital Investments's 13F filing for Q1 2023, filed 31 Jul 2025.